Skip to main navigation
Pharvaris N.V logo
Main Menu

Header Nav

  • Our science
  • our pipeline
  • disease focus: HAE
  • HAE community
  • clinical trials
  • About us
    • about us
    • join us
    • Contact
  • Investors
Investor Menu

IR Nav

  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
    • Publications
  • Financials
    • SEC Filings
  • Stock
    • Stock Performance
    • Analyst Coverage
  • Corporate Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Committee Composition
  • Resources
    • FAQ
    • Contact Us
    • Email Alerts

FAQ

Breadcrumb

Home / Investor Relations / IR RESOURCES / IR RESOURCES >> FAQ
  • Where is Pharvaris’ corporate headquarters?
    Pharvaris’ corporate headquarters is located in Zug, Switzerland (Grafenauweg 8, CH-6300 Zug, Switzerland)
  • On what stock exchange are Pharvaris’ shares traded, and what is the ticker symbol?
    The Pharvaris symbol is PHVS and its shares are traded on the Nasdaq Global Select Market.
  • When did Pharvaris go public?
    Pharvaris’ common stock began trading on The Nasdaq Global Select Market on February 5, 2021.
  • When does Pharvaris’ fiscal year end?
    December 31, 2021. 
  • Does Pharvaris pay dividends?
    Pharvaris currently intends to retain all available funds and any future earnings to fund the development and expansion of its business. Pharvaris does not anticipate paying any cash dividends in the foreseeable future.
  • Who is Pharvaris' auditor?
    Pharvaris’ auditor is PricewaterhouseCoopers Accountants N.V. 
  • Where can I find Pharvaris’ SEC filings? Where can I download and view quarterly and annual reports?
    Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov.
  • How can I obtain further information or materials on Pharvaris?
    Investor relations inquiries may be submitted by email to info@pharvaris.com. Please include your name and phone number with your email correspondence.

Toolkit

Print Page
Print Page
Email Alerts
Email Alerts
IR Contacts
IR Contacts

Footer Links

Privacy     Cookie notice     Terms of Use

Social Links

  • Pharvaris 2020 - © All rights reserved